Last Posted: Jul 26, 2018
- Clinical Impact and Cost-Effectiveness of a 176-Condition Expanded Carrier Screen
KA Beachamp et al, BioRXIV, July 2018 - Cost-effective screening of DNMT3A coding sequence identifies somatic mutation in pediatric T-cell acute lymphoblastic leukemia.
Szarzynska-Zawadzka Bronislawa et al. European journal of haematology 2017 Dec 99(6) 514-519 - The Value of Evidence in the Decision-Making Process for Reimbursement of Pharmacogenetic Dosing of Warfarin.
Janzic Andrej et al. American journal of cardiovascular drugs : drugs, devices, and other interventions 2017 Oct 17(5) 399-408 - The Price of Precision: Genetic Testing and Drug Costs in America.
Rich Kelly et al. Genetic testing and molecular biomarkers 2018 Jul 22(7) 403-404 - Buccal swab genomic DNA fragmentation predicts likelihood of successful HLA genotyping by next-generation sequencing.
Montgomery Maureen C et al. Human immunology 2017 Oct 78(10) 634-641 - Is genome-guided cancer treatment hyped?
Kaiser Jocelyn et al. Science (New York, N.Y.) 2018 Apr 360(6387) 365 - Are Payers Ready To Address The Financial Challenges Associated With Gene Therapy?
Health Affairs Blog, June 28, 2018 - Insurance coverage for genomic tests.
Phillips Kathryn A et al. Science (New York, N.Y.) 2018 Apr 360(6386) 278-279 - 21-Gene recurrence score testing among Medicare beneficiaries with breast cancer in 2010-2013.
Lynch Julie A et al. Genetics in medicine : official journal of the American College of Medical Genetics 2017 Oct 19(10) 1134-1143 - Hereditary ATTR amyloidosis: burden of illness and diagnostic challenges.
Gertz Morie A et al. The American journal of managed care 2017 Jun 23(7 Suppl) S107-S112
No hay comentarios:
Publicar un comentario